Abstract: Some biologically active organotellurium compounds exhibit inhibitory potency against cathepsin B. In this study, an alkyl derivative, viz. [CH 3 (CH 2 ) 2 C(I) = C(H)] (nBu)TeI 2 , 1, has been structurally characterised by X-ray crystallography and shown to be coordinated within a C 2 I 2 donor set. When the stereochemically active lone pair of electrons is taken into account, a distorted trigonal bipyramidal geometry results with the iodide atoms in axial positions. Both intra-and inter-molecular Te···I interactions are also noted. If all interactions are considered, the coordination geometry is based on a Ψ-pentagonal bipyramidal geometry. An unusual feature of the structure is the curving of the functionalised C 5 chain. This feature has been explored by DFT methods and shown to arise as a result of close C-H···I interactions. A docking study (cathepsin B) was performed to understand the inhibition mechanism and to compare the new results with previous observations. Notably, 1 has the same pose exhibited by analogous biologically active compounds with aryl groups. Thus, the present study suggests that (alkyl) 2 TeX 2 compounds should also be evaluated for biological activity.
Introduction
The lysosomal cysteine protease, cathepsin B, hereafter Cat B, is responsible for the degradation and processing of proteins in living organisms [1, 2] . The structure is characterised by a thiol in the cysteine residue, Cys29, and a histidine, His199, in the catalytic site [3, 4] , and therefore, in the context of metal-based drugs, offers the opportunity for coordination to metal centres. Herein, the interaction of an organotellurium(IV) compound, diiodo(2-iodopent-1-en-1-yl)butyl-λ 4 -tellane (1), Figure 1 , with Cat B is investigated employing docking studies.
The important role of Cat B is indicated in a variety of human disease. Amongst these is tumour metastasis [5] , as the metastatic potential of cancer cells is moderated by Cat B [6] . Along with other proteases, Cat B is considered both as a biomarker and a therapeutic target, especially in malignant melanoma [7] . Neurodegenerative disorders are also thought to involve a role for Cat B [8] . In patients afflicted with rheumatoid arthritis, a disorder associated with the degradation of the extracellular matrix components [9] , Cat B has been reported to be up-regulated [10] . Thus, Cat B presents an important target in developing therapies in cancer, arthritis and other disease. This being the case, the generation of selective inhibitors of Cat B is a definite option in drug development. Good inhibitors, as discussed below, have been shown to typically bind amino acids in the S1′ and S2′ sub-sites [2] .
In this context, the tellurium atom in a number of organotellurium compounds has been shown to bind sulphur at the Cys29 site thereby rendering the protein inactive [9] [10] [11] [12] . The most promising tellurium-based therapeutic agent, ammonium trichloro (dioxoethylene-O,O′) tellurate (AS101), 2 in Figure 1 , was the first tellurium compound shown to inhibit non-lysosomal Cat B [11, 13] . In developing new therapeutic organotellurium(IV) compounds, Cunha et al. showed organotelluranes to be irreversible inhibitors of cysteine cathepsins [12] . Further, strategic modification of substituents can be exploited to alter specificity for different cathepsins, e.g. Cat B, L, S and K, and to relate inhibition efficiency to sub-site specificity [12] . In the present study, a docking study of those compounds, i.e. dichloro-(2-chloro-phenylvinyl)-4-methoxyphenyl-tellurium(IV) (3 in Figure 1 ), was performed to understand the inhibition mechanism [14] .
As a continuation of on-going interest in tellurium compounds and their activity in biological environments, the present docking study of a mixed alkyl/alkenyl derivative, 1, was undertaken. The study was motivated in order to determine whether inhibition of Cat B by related compounds required the presence of an aryl group(s). The present report details the crystal structure determination of 1, its geometry optimised structure as well as docking studies in Cat B.
Experimental Synthesis and crystal growth
Compound 1 was synthesised and characterised as per the literature procedure [15] . Crystals for the X-ray structure determination were obtained by slow evaporation of its chloroform/petroleum ether (1/1 v/v) solution.
Crystal structure determination
Intensity data for 1 were measured at 98 K on a Rigaku AFC12κ/SAT-URN724 diffractometer fitted with MoKα radiation (λ = 0.71073 Å). 
Tab. 1:
Crystallographic data and refinement details for 1. Data processing and absorption corrections were accomplished with CrystalClear [16] and ABSCOR [17] , respectively. Unit cell data, X-ray data collection parameters, and details of the structure refinement are given in Table 1 . The structure was solved by direct methods [18] and full-matrix least-squares [19] , respectively, were located 0.91 and 0.77 Å from the Te atom. Two reflections, i.e. (3 1 2) and (5 9 2), were omitted from the final cycles of refinement owing to poor agreement. The programs WinGX [20] , PLATON [21] , ORTEP-3 for Windows [20] , Qmol [22] and DIAMOND [23] were also used in the study.
Computational chemistry
The calculations were performed using the computational package Firefly [24, 25] . The structures were optimised at the B3LYP/LANL2Zdp level [26] [27] [28] [29] [30] [31] with an algorithm based in quadratic approximation (QA) [32] and 10 -5 a.u. for the threshold gradient value. The inner electrons for tellurium and iodide were treated with the effective core potential (ECP) approximation [26] [27] [28] [29] [30] [31] . The NBO donor-acceptor pairs were checked. The interaction energies were calculated according to second-order stabilisation (E2PRT) and steric exchange energies of NBO analyses [33] . Structures, charts and surfaces, were drawn using the wxMacMolPlt and JMol softwares [34, 35] .
Docking studies
The GOLD program (version 4.1.1) [36] was used to perform the docking calculation of "ligand" 1 using a genetic algorithm to explore the full range of ligand conformational flexibility and partial flexibility of the protein binding site. Each conformational result of the ligand has a score (GOLDScore) given by the following sum:
where Shb_ext is the protein-ligand hydrogen bonding score, and Shb_int the internal hydrogen bonding of the ligand. The coordinates for the investigated protein, Cat B, were obtained from the PDB and PDBsum sites [37] . Before the calculations, the hydrogen atoms were attached to the protein and all water molecules and the non-protein-atoms removed. On the basis of previous studies [5, 6, 12] , which indicate the tellurium atom of related organotellurium(IV) compounds binds the protein at the S-Cys29 site, the docking calculations were conducted with a sphere of 12 Å about the active site with both S-Cys29 and His199 in their ionised forms, i.e. the thiol is pre-activated by transferring its proton to the ring-imine-nitrogen atom leading to the thiolate/ imidazolium tautomer. To inhibit the protein, the tellurium atom must bind to S-Cys29 [13, 38] indicating that one iodide atom must be a leaving group. Therefore, the following calculations were performed: (i) analysis was made with the complete molecule of 1 with the protein, and (ii) since the tellurium-bound iodide atoms are not equivalent, calculations were performed to ascertain which of these was the better leaving group, i.e. yielding 1′ which corresponds to 1 less one tellurium-bound iodide, i.e. {[CH 3 (CH 2 ) 2 C(I) = C(H)](nBu)TeI} + . The docking results were plotted using D.S. Visualiser v3.5 [39] .
Results

Experimental molecular structure
The molecular structure of 1, as determined by X-ray crystallography, is shown in Figure 2 and selected geometric parameters are collated in Table 2 . The immediate coordination geometry of the tellurium atom is defined by two iodide atoms and two carbon atoms. These donor atoms along with a stereochemically active lone pair of electrons define a distorted trigonal bipyramidal geometry with the iodide atoms being mutually trans defining an axial angle of 176.196(13)°. The tellurium atom also forms a weak intramolecular interaction with the I3 atom of the vinyl group, 3.5455(19) Å, as well as intermolecularly with I2 i , 3.845(2) Å; symmetry operation i: -x, 1 - y, 1 - z. The participation of the I2 atom in the secondary interaction explains the elongation of the Te-I2 bond length, i.e. 2.9334(13) Å, with respect to the Te-I1 bond length of 2.9083(13) Å. Both of the Te···I secondary interactions are less than the sum of the van der Waals radii of Te and I, i.e. 4.04 Å [40] . In consideration of the additional Te···I interactions that occur approximately normal to the axially-bound iodide atoms, the coordination geometry may be described as distorted Ψ-pentagonal bipyramidal. The configuration about the vinyl C1 = C2 bond is Z. An unexpected feature of the structure is the conformation of the C 5 chain. Whereas the n-butyl group exhibits an open, all-trans conformation with the C6-C7-C8-C9 torsion angle being 178.6(5)°, a pronounced kink is observed in the C 5 chain as seen in the values of the C1-C2-C3-C4 and C2-C3-C4-C5 torsion angles of -118.1(6) and 57.5(7)°, respectively.
There are three literature precedents for 1, i.e. with the general formula [RC(X′) = C(H)](nBu)TeX 2 . These, i.e. X = X′ = Cl and R = Ph [41] , X = X′ = Br and R = CH 2 OH [42] and X = Cl, X′ = Br and R = Cy [43] , each feature a Z configuration about the vinyl bond and an intramolecular Te···X interaction. 
Theoretical molecular structures
The unrestrained optimisation of the structure of 1 gave rise to two conformations with very similar minimumenergy (see below). In one conformation the n-propyl substituent at the C = C double bond is bent, hereafter named as the closed conformer. In the second, open conformer, the aliphatic substituent is straight, see Figure 4 .
Both conformations have essentially the same energy, i.e. they are equally stable, Table 3 , with the open conformer being marginally more stable. Initially, it was anticipated that the closed conformation would be less stable due to the higher steric hindrance imposed by bent n-propyl substituent (Table 4 ). According to the data in Table 5 , the difference between steric effects is actually small and might be compensated by weak intramolecular C-H ... I hydrogen bonds, Figure 5 and Table 5 . The NBO analysis indicates hyperconjugation between the I3 and methylene-H atoms. Even though the distance between donor-acceptor atoms of the methyl-H···I interaction (C···I = 4.92 Å and H···I = 3.85 Å) are 15% greater than the sum of their van der Waals radii [40, 45] , the C5-H5···I2 interactions are identified by the NBO analysis as weak hyperconjugation between the lone pair of the iodide and anti-bonding orbitals of the C(methyl)-H bond (n I → σ* C-H ), Figure 5c , having a second-order stabilisation energy of ca. 0.1 kcal·mol -1 . It should be noted that the crystallographic structure has a conformation close to that of the closed conformer with a r.m.s. deviation for their superposition of 0.06 Å, Figure 6 .
Docking results
Docking experiments were conducted with 1 and 1′, i.e. compound 1 less one iodide (see Section Docking studies). The calculations showed that the better leaving atom Moreover, the same value was found in the crystal structure of the sarcosine oxidase complex with a tellurium compound [47] and in related docking studies [14, 38] . Given that two distinct conformations were found for 1, with only a small energy difference indicated from the computational study (see above), both were evaluated in the docking study. It is interesting to note that, regardless of the initial conformation, the final conformation in the active site was the closed form, hereafter Closed 1′. An image showing the interaction of 1′ with the active site of Cat B is shown in Figure 7 . In addition to the formation of the Te-S bond, Te···O(Gly27) and Te···H(Gly73) interactions are noted; Table 6 collates a summary of all the nearest contacts in the active site. In previous work, similar interactions between the tellurium "ligand" and the active site of Cat B were seen (see below) [14, 38] . Figure 8 shows a detailed view of the immediate coordination environment about the tellurium atom bound to the active site of Cat B. It is remarkable the disposition of the donor atoms matches very closely those found in the crystal structure of 1, Figure 8 insert.
Finally, Figure 9 shows the superimposition of the interacting alkyl-derivative 1′ and benzyl-derivative 3′, i.e. 3 less one chloride, in the active site of Cat B. In accord with Schechter and Berger's nomenclature [48] , the active site of all proteases comprises several sub-sites. The subsites on the N-terminus are named S1, S2, S3···Sn, while those on the C-terminus are labelled S1′, S2′, S3′···Sn′. Previous work revealed that the inhibitory activity is dependent on the binding modes of the ligands and simultaneous binding to the S1′ and S2′ sub-sites results in significant inhibitory activity. In the present work, the close superimposition of the two ligands, 1′ and 3′, suggests that as far as interacting with the active site is concerned, the alkyl organotellurium derivative is just as effective in binding as the benzyl derivative.
Conclusions
Biologically active organotellurium compounds often inhibit Cat B. Crystallography on an alkyl derivative, [CH 3 (CH 2 ) 2 C(I) = C(H)](nBu)TeI 2 , 1, reveals a C 2 I 2 donor set but, allowing for the stereochemically active lone pair of electrons, along with intra-and inter-molecular Te···I interactions, the coordination geometry is based on a Ψ-pentagonal bipyramid. Computational docking of 1′, i.e. 1 less one iodide, in Cat B indicates the formation of a Te-S(cys29) bond and a coordination environment analogous to that seen in the crystal structure of 1. Notably, the interaction of 1′ is very similar to those exhibited by benzyl organotellurium species suggesting biological screening of alkyl organotellurium compounds is likely to provide promising outcomes, especially when these derivatives are generally regarded as having low toxicity [49, 50] .
